| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Loxo/Lilly |
| Recipient: You |
| Company: Illumina |
| Recipient: You |
| Company: AADi |
| Recipient: You |
| Company: Foundation Medicine |
| Recipient: You |
| Company: Relay Therapeutics |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Pheon Therapeutics |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Novartis |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: NanoCarrier |
| Recipient: Your Institution |
| Company: Northwest Biotherapeutics |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Berg Pharma |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Fujifilm |
| Recipient: Your Institution |
| Company: PharmaMar |
| Recipient: Your Institution |
| Company: D3 Oncology Solutions |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Amgen |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Multivir |
| Recipient: Your Institution |
| Company: Blueprint Medicines |
| Recipient: Your Institution |
| Company: LOXO |
| Recipient: Your Institution |
| Company: Vegenics |
| Recipient: Your Institution |
| Company: Takeda |
| Recipient: Your Institution |
| Company: Alfasigma |
| Recipient: Your Institution |
| Company: Agensys |
| Recipient: Your Institution |
| Company: Idera |
| Recipient: Your Institution |
| Company: Boston Biomedical |
| Recipient: Your Institution |
| Company: Inhibrx |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Amgen |
| Recipient: Your Institution |
| Company: Turningpoint Therapeutics |
| Recipient: Your Institution |
| Company: Relay Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: Medscape |
| Recipient: You |
| Company: Clinical Care Options |
| Recipient: You |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|